Production and characterization of egg yolk antibodies to human rotavirus

Dong Hyuk Jung, Kang Young Kim, Shien Young Kang, Han Soo Joo, Hoo Kil Jung, Sung Seob Yun, Suk Lak Juhn

Research output: Contribution to journalArticle

Abstract

Antibody response in egg-laying hens was examined following repeated immunization with a human rotavirus vaccine. Four different rotavirus subtypes which have been isolated from fecal samples of infants in Korea were used in vaccine preparation. Following vaccination in hens at 0, 2, 4, and 8 weeks, neutralization antibody to rotavirus subtypes was first detected at 3 weeks and antibody titer was peaked at 8 weeks after the first vaccination. High antibody titers were maintained for up to 10 weeks after the first vaccination. The egg yolk antibody titers were stable with slight decrease (29.65%) by freeze-drying process. A high concentration (50 g/kg) of the yolk antibodies caused no clinical sign, body weight loss, and necropsy lesion following oral administration in mice. In addition, the yolk antibodies did not cause mortality for suckling mice when they were inoculated intracerebrally. Furthermore, yolk antibodies caused no cytopathic effects on two different cell lines. In conclusion, egg yolk containing high concentrations of human rotavirus antibodies can be produced by immunization in hens. The egg yolks appear to be safe for human consumption.

Original languageEnglish (US)
Pages (from-to)379-385
Number of pages7
JournalJournal of Bacteriology and Virology
Volume31
Issue number4
StatePublished - Jan 1 2001

Keywords

  • Egg-yolk
  • Human rotavirus vaccine
  • Immunoglobulin-Y
  • Neutralization antibody titer

Fingerprint Dive into the research topics of 'Production and characterization of egg yolk antibodies to human rotavirus'. Together they form a unique fingerprint.

  • Cite this

    Jung, D. H., Kim, K. Y., Kang, S. Y., Joo, H. S., Jung, H. K., Yun, S. S., & Juhn, S. L. (2001). Production and characterization of egg yolk antibodies to human rotavirus. Journal of Bacteriology and Virology, 31(4), 379-385.